News

New Medication Release of Symbravo
The FDA recently approved Symbravo® (meloxicam/rizatriptan) for the acute treatment of migraine with or without…

Carlisle Medical 2025 October Excellence In Caring
Carlisle Medical case managers are recognized throughout the industry for their commitment to both of…

New Medication Release of Tonmya
The FDA has approved Tonmya (cyclobenzaprine HCl sublingual tablet) for the treatment of fibromyalgia in…

Carlisle Medical 2025 September Excellence In Caring
Relationships are at the heart of every interaction at Carlisle Medical. Recently, a valued client…

Carlisle Medical Will Be Exhibiting at the 2025 MSIA Fall Conference
Carlisle Medical Will Be Exhibiting at the 2025 MSIA Fall Conference on October 30, 2025….

Carlisle Medical Will Be Exhibiting at the 2025 Mid-South Workers Compensation Conference
Carlisle Medical will be exhibiting at the 2025 Mid-South Workers Compensation Conference Mid-South Workers Compensation ConferenceShannon Seebert,…

Carlisle Medical Will Be Exhibiting at the 2025 TN PRIMA Annual Conference
Carlisle Medical will be exhibiting at the 2025 TN PRIMA Annual Conference.Shannon Seebert, Regional Sales…

Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS)
Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS) on…

Carlisle Medical Will Be Exhibiting at the 2025 Fall MASI Conference
Carlisle Medical Will Be Exhibiting at the 2025 MASI Fall Conference on October 1 -3,…

Join Us for the Beat the Heat Webinar On August 28, 2025
Please join Carlisle Medical for this upcoming webinar on heat factors and workers. This webinar…